| BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ, S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. AMSTERDAM: Oxford University Press, 2021, vol. 32, No 4, p. 452-465. ISSN 0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2020.12.007. |
Other formats:
BibTeX
LaTeX
RIS
@article{1786779,
author = {Bossi, P. and Chan, A. T. and Licitra, L. and Trama, A. and Orlandi, E. and Hui, E. P. and Halámková, Jana and Mattheis, S. and Baujat, B. and Hardillo, J. and Smeele, L. and van Herpen, C. and Castro, A. and Machiels, J. P.},
article_location = {AMSTERDAM},
article_number = {4},
doi = {http://dx.doi.org/10.1016/j.annonc.2020.12.007},
keywords = {nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up},
language = {eng},
issn = {0923-7534},
journal = {Annals of Oncology},
title = {Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up},
url = {https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub},
volume = {32},
year = {2021}
}
TY - JOUR
ID - 1786779
AU - Bossi, P. - Chan, A. T. - Licitra, L. - Trama, A. - Orlandi, E. - Hui, E. P. - Halámková, Jana - Mattheis, S. - Baujat, B. - Hardillo, J. - Smeele, L. - van Herpen, C. - Castro, A. - Machiels, J. P.
PY - 2021
TI - Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
JF - Annals of Oncology
VL - 32
IS - 4
SP - 452-465
EP - 452-465
PB - Oxford University Press
SN - 09237534
KW - nasopharyngeal cancer
KW - Clinical Practice Guidelines
KW - diagnosis
KW - treatment
KW - follow-up
UR - https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub
N2 - This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
ER -
BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ, S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. \textit{Annals of Oncology}. AMSTERDAM: Oxford University Press, 2021, vol.~32, No~4, p.~452-465. ISSN~0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2020.12.007.
|
